Triple

T12544233
Position Surface form Disambiguated ID Type / Status
Subject Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc E299919 entity
Predicate hasMember P10 FINISHED
Object c-Myc E989513 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: c-Myc | Statement: [Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc, hasMember, c-Myc]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: c-Myc
Context triple: [Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc, hasMember, c-Myc]
  • A. c-Myc chosen
    c-Myc is a proto-oncogene transcription factor that regulates cell growth, proliferation, and metabolism and is frequently dysregulated in cancer.
  • B. CDK4
    CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
  • C. CDK6
    CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
  • D. Sox2
    Sox2 is a key transcription factor that maintains stem cell pluripotency and self-renewal and is widely used in cellular reprogramming.
  • E. HER2 receptor
    The HER2 receptor is a cell surface protein and member of the epidermal growth factor receptor family that, when overexpressed, drives the growth of certain aggressive breast and other cancers.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6ada707008190aaec1238117c9379 completed April 8, 2026, 7:33 p.m.
NER Named-entity recognition batch_69d9547d6df4819080db8415d386ed38 completed April 10, 2026, 7:50 p.m.
NED1 Entity disambiguation (via context triple) batch_69f65eb317148190990d47f50324a1b1 completed May 2, 2026, 8:29 p.m.
Created at: April 8, 2026, 9:57 p.m.